View Emergent BioSolutions Inc. EBS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals. What Happened: On Thursday prior ...

Emergent BioSolutions Inc.’s ruination of 15 million doses of COVID-19 vaccine at its Baltimore plant was not as unexpected as the Gaithersburg-based company would have the public believe, an investor ...

Emergent BioSolutions remains under significant pressure, with persistent revenue, margin, and earnings declines. Learn more ...

Emergent enters into a forbearance agreement, securing flexible credit terms on its existing credit agreement. Emergent BioSolutions sees first-quarter revenue between $200 million and $250 million, ...

How does the mpox outbreak impact Emergent BioSolutions? The only approved vaccine for preventing mpox is made by Bavarian Nordic. However, the U.S. Centers for Disease Control and Prevention (CDC) ...

As Korean food producers navigate rising input costs, margin pressure, and raw material price volatility, biosolutions — ...

Emergent BioSolutions' top line has been nosediving in recent quarters. The company's operations are also unprofitable, and the business is burning through cash. Its flagship product, Narcan, will ...